Ultomiris 300 mg/3 mL concentrate for solution for infusion
ALXN1210-NMO-317
Phase 3 small_molecule active
Quick answer
Ultomiris 300 mg/3 mL concentrate for solution for infusion for Neuromyelitis Optica Spectrum Disorder (NMOSD) is a Phase 3 program (small_molecule) at Alexion Europe SAS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alexion Europe SAS
- Indication
- Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active